New facility offers genetic testing, counselling and personalised treatment plans to enable early diagnosis and precision-led care
The capacity addition to be implemented in a phased manner amid evolving business and market dynamics
Shares issued under ESOP 2008 and MESOP 2018 plans following exercise of vested stock options, in compliance with SEBI disclosure norms
The study evaluated oral semaglutide in young patients with type 2 diabetes and found it delivered a superior reduction in HbA1c
Denosumab biosimilars approved in Canada to expand access for osteoporosis and cancer-related bone conditions
The transition from an outsourced MRI model to an in-house facility marks more than an infrastructure upgrade
Deal includes 13 branded generic products across 55+ countries; acquisition expected to strengthen global anti-infective portfolio and expand regulated market presence
The investigational therapy, MDX2003, is designed to go after cancer cells with a multi-pronged immune attack
Growth was broad-based across segments
The ETHICON 4000 Stapler and ETHICON 3D Reloads are now approved for use in both open and laparoscopic surgeries across the European Union
Subscribe To Our Newsletter & Stay Updated
